-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 9, Xianju Pharmaceutical announced that it had recently received the "Drug Supplementary Application Approval Notice" for finasteride tablets approved and issued by the National Medical Products Administration.
Finasteride is a 4-azasteroid compound.
Finasteride tablets, specification: 5mg, first obtained US FDA marketing approval in June 1992, with the trade name "PROSCAR".
Finasteride tablets, specification: 1mg, first obtained US FDA marketing approval in December 1997, with the trade name "PROPECIA".